Accelerated Cure Project Launches MS Repository
Initial sample base of 1,000 subjects is first step toward goal of 10,000
Contributions to $2.5 ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Tuesday, October 31
Friday, October 27
DIETARY SUPPLEMENT RESEARCH
by
All About MS
on Fri 27 Oct 2006 12:00 AM CST
SIGNIFICANT ADVANCES IN DIETARY SUPPLEMENT RESEARCH RELEASED IN
ANNUAL BIBLIOGRAPHY (2005) The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) announces ... more » Thursday, October 26
Treatment of MS at the First Demyelinating Event
by
All About MS
on Thu 26 Oct 2006 10:24 AM CST
Treatment of Multiple Sclerosis at the First Demyelinating Event
Delays Progression: Presented at ANA By Paula Moyer CHICAGO, IL -- October 12, 2006 -- Patients ... more » Sunday, October 22
B-cells damage axons during MS
by
All About MS
on Sun 22 Oct 2006 12:00 AM CST
New information in emerging area of MS research could aid therapy Friday, October 13
impact of MS in daily life study
by
All About MS
on Fri 13 Oct 2006 12:00 AM CST
Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life Background: The ... more »
Campath more effective than Rebif
by
All About MS
on Fri 13 Oct 2006 12:00 AM CST
Campath more effective than Rebif Thursday, October 12
Gene found that helps combat MS
by
All About MS
on Thu 12 Oct 2006 02:00 AM CST
BBC NEWS Gene found that helps combat MS A gene that helps to stave off the effects of multiple sclerosis (MS) has been discovered by ... more » Wednesday, October 11
independent Multiple Sclerosis Advisory Board
by
All About MS
on Wed 11 Oct 2006 12:00 AM CST
Chromos announces independent Multiple Sclerosis Advisory Board BURNABY, B. C., Chromos Molecular Systems Inc. (TSX: CHR) has formed a Multiple Sclerosis ... more » Tuesday, October 10
Copaxone® Antibodies Do Not Impact It’s Established And Sustained Long-Term Efficacy
by
All About MS
on Tue 10 Oct 2006 10:52 AM CST
New Data Confirmed Antibodies To Copaxone® Do Not Impact It’s Established And Sustained Long-Term Efficacy In Multiple Sclerosis
Monday, October 9
Health Canada Grants Approval of Tysabri
by
All About MS
on Mon 09 Oct 2006 12:00 AM CST
Health Canada Grants Approval of Tysabri(TM) (Natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review First new class of treatment in ten years ... more » Sunday, October 8
Betaferon Causes Less Injection Site Pain and Injection Site Reactions Than Rebif
by
All About MS
on Sun 08 Oct 2006 12:00 AM CST
Betaferon Causes Less Injection Site Pain and Injection Site Reactions Than Rebif in Patients With Multiple Sclerosis: Presented at ECTRIMS MADRID, SPAIN – ... more » Sunday, October 1
New Formulation for Rebif
by
All About MS
on Sun 01 Oct 2006 03:14 PM CST
New Formulation Rebif for Relapsing Multiple Sclerosis Lowers Immunogenicity and Improves Tolerability: Presented at ECTRIMS MADRID, SPAIN – September 30, 2006 – At ... more »
Oral drug, Fingolimod, phase 2 study
by
All About MS
on Sun 01 Oct 2006 03:09 PM CST
Oral FTY720 (Fingolimod) for Relapsing Multiple Sclerosis Shows Sustained Benefits for Up to 2 Years: Presented at ECTRIMS By Bruce Sylvester MADRID, SPAIN ... more » |
||